XML 22 R6.htm IDEA: XBRL DOCUMENT v3.6.0.2
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
UNITED STATES
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
UNITED STATES
Retained Earnings
AOCI Attributable to Parent
Treasury Stock
Noncontrolling Interest
Beginning Balance at Dec. 31, 2013 $ 1,060,497   $ 77 $ 906,481   $ 614,340 $ 16,486 $ (599,816) $ 122,929
Beginning Balance (in shares) at Dec. 31, 2013     77,048,000            
Shares issued on vesting of restricted stock 1   $ 1            
Shares issued on vesting of restricted stock (in shares)     883,000            
Clawback of shares from settlement with former management (193,434)                
Purchase of minority interest in joint venture (525)     (525)          
Shares issued on exercise of stock options and warrants $ 10,088   $ 1 10,087          
Shares issued on exercise of stock options and warrants (in shares) 1,172,000   1,332,000            
Tax benefit of stock option exercises $ 10,703     10,703          
Tax effect on formation of joint venture (4,316)     (4,316)          
Compensation expense in connection with restricted stock and stock options 18,492     18,492          
Shares repurchased on the open market (193,434)             (193,434)  
Cost of shares repurchased on vesting of restricted stock and exercise of stock options (19,179)             (19,179)  
Non-controlling interest of acquired companies 11,526               11,526
Payments from non-controlling interest holders 549               549
Change in redemption value of redeemable non-controlling interest holders (3,051)         (3,051)      
Net income (loss) 118,822         103,723     15,099
Foreign currency translation (40,672)           (40,672)    
Distributions to joint ventures (18,064)         (1,193)     (16,871)
Ending Balance at Dec. 31, 2014 951,437   $ 79 940,922   713,819 (24,186) (812,429) 133,232
Ending Balance (in shares) at Dec. 31, 2014     79,263,000            
Issuance of common stock related to acquisition of interest in joint venture 15,703     15,703          
Issuance of common stock related to acquisition of interest in joint venture (in shares)     465,000            
Shares issued on vesting of restricted stock 1   $ 1            
Shares issued on vesting of restricted stock (in shares)     806,000            
Clawback of shares from settlement with former management (12,391)                
Purchase of minority interest in joint venture 18,371     3,620         14,751
Shares issued on exercise of stock options and warrants $ 321     321          
Shares issued on exercise of stock options and warrants (in shares) 75,000   75,000            
Tax benefit of stock option exercises $ 2,006     2,006          
Compensation expense in connection with restricted stock and stock options 11,449     11,449          
Shares repurchased on the open market (12,391)             (12,391)  
Cost of shares repurchased on vesting of restricted stock and exercise of stock options (12,359)             (12,359)  
Non-controlling interest of acquired companies (9,168)               (9,168)
Payments from non-controlling interest holders 3,523               3,523
Change in redemption value of redeemable non-controlling interest holders (5,015)         (5,015)      
Change in fair value of available for sale securities (703)           (703)    
Net income (loss) (188,930)         (189,303)     373
Foreign currency translation (36,004)           (36,004)    
Distributions to joint ventures (22,080)         (4,740)     (17,340)
Ending Balance at Dec. 31, 2015 716,161   $ 80 974,021   514,761 (60,893) (837,179) 125,371
Ending Balance (in shares) at Dec. 31, 2015     80,609,000            
Shares issued on vesting of restricted stock 2   $ 2            
Shares issued on vesting of restricted stock (in shares)     1,700,000            
Clawback of shares from settlement with former management $ (5,153)             (5,153)  
Purchase of minority interest in joint venture   $ 1,114     $ 1,114        
Shares issued on exercise of stock options and warrants (in shares) 0                
Tax deficiency of stock option exercises and restricted stock vestings $ 445     445          
Compensation expense in connection with restricted stock and stock options 6,805     6,805          
Shares issued on repurchase of convertible notes 51,325   $ 7 51,318          
Shares issued on repurchase of convertible notes (in shares)     7,408,000            
Repurchase of equity portion of convertible notes (1,164)     (1,164)          
Cost of shares repurchased on vesting of restricted stock and exercise of stock options (620)             (620)  
Sale of minority interest in Umbro China 2,500     718         1,782
Payments from non-controlling interest holders 506               506
Tax effect of repurchase of convertible notes 413     413          
Tax benefit related to amortization of convertible notes' discount 154     154          
Change in redemption value of redeemable non-controlling interest holders (97)         (97)      
Change in fair value of available for sale securities (1,990)           (1,990)    
Net income (loss) (249,509)         (252,134)     2,625
Foreign currency translation (7,640)     (95)     (7,545)    
Distributions to joint ventures (18,608)         (7,615)     (10,993)
Ending Balance at Dec. 31, 2016 $ 494,644   $ 89 $ 1,033,729   $ 254,915 $ (70,428) $ (842,952) $ 119,291
Ending Balance (in shares) at Dec. 31, 2016     89,717,000